For further details see:
Amgen to acquire Five Prime Therapeutics for $1.9BFor further details see:
Amgen to acquire Five Prime Therapeutics for $1.9BMarket Wire News is a media platform, the information on this page was provided by SeekingAlpha via Quote Media. Read our full disclaimer.
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
News, Short Squeeze, Breakout and More Instantly...
2024-05-26 06:53:00 ET With some promising clinical trial results in hand and more that could be on the way relatively soon, Amgen 's (NASDAQ: AMGN) latest attempt to develop a therapy for obesity is looking like it could be a contender for the crown that's currently jointly held by...
Thursday, Verastem Oncology (NASDAQ:VSTM) announced the initial interim safety and efficacy results from the ongoing RAMP 205 Phase 1/2 t...
2024-05-22 07:30:10 ET Wells Fargo analyst issues OVERWEIGHT recommendation for AMGN on May 22, 2024 05:12AM ET. The previous analyst recommendation was Overweight. AMGN was trading at $314.85 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...